159 related articles for article (PubMed ID: 22038367)
1. Correlation analysis on total lymphocyte count and CD4 count in HIV-infected patients: a retrospective evaluation.
Wang Y; Liang S; Yu E; Guo J; Li Z; Wang Z; Du Y
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):712. PubMed ID: 22038367
[TBL] [Abstract][Full Text] [Related]
2. Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings.
Mahajan AP; Hogan JW; Snyder B; Kumarasamy N; Mehta K; Solomon S; Carpenter CC; Mayer KH; Flanigan TP
J Acquir Immune Defic Syndr; 2004 May; 36(1):567-75. PubMed ID: 15097299
[TBL] [Abstract][Full Text] [Related]
3. Total lymphocyte count as a surrogate marker to predict CD4 count in human immunodeficiency virus-infected children: a retrospective evaluation.
Wang Y; Li Y; Wang C; Liang S; Guo J; Li Z; Zhang M; Li W
Pediatr Infect Dis J; 2012 Jan; 31(1):61-3. PubMed ID: 22217967
[TBL] [Abstract][Full Text] [Related]
4. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.
Spacek LA; Griswold M; Quinn TC; Moore RD
AIDS; 2003 Jun; 17(9):1311-7. PubMed ID: 12799552
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jirovecii prophylaxis discontinuation based upon total lymphocyte count in HIV-infected adults treated with antiretroviral therapy.
Cheung C; Shuter J
Int J STD AIDS; 2010 Jun; 21(6):406-9. PubMed ID: 20606220
[TBL] [Abstract][Full Text] [Related]
6. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.
Obirikorang C; Quaye L; Acheampong I
BMC Infect Dis; 2012 Jun; 12():128. PubMed ID: 22676809
[TBL] [Abstract][Full Text] [Related]
7. Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.
Anastos K; Shi Q; French AL; Levine A; Greenblatt RM; Williams C; DeHovitz J; Delapenha R; Hoover DR
J Acquir Immune Defic Syndr; 2004 Apr; 35(4):383-92. PubMed ID: 15097155
[TBL] [Abstract][Full Text] [Related]
8. Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.
Gupta A; Gupte N; Bhosale R; Kakrani A; Kulkarni V; Nayak U; Thakar M; Sastry J; Bollinger RC;
J Acquir Immune Defic Syndr; 2007 Nov; 46(3):338-42. PubMed ID: 17846559
[TBL] [Abstract][Full Text] [Related]
9. Evaluating total lymphocyte count as a surrogate marker for CD4 cell count in the management of HIV-infected patients in resource-limited settings: a study from China.
Chen J; Li W; Huang X; Guo C; Zou R; Yang Q; Zhang H; Zhang T; Chen H; Wu H
PLoS One; 2013; 8(7):e69704. PubMed ID: 23874985
[TBL] [Abstract][Full Text] [Related]
10. Correlation analysis on total lymphocyte count and CD4 count of HIV-infected patients.
Liu FR; Guo F; Ye JJ; Xiong CF; Zhou PL; Yin JG; Ye LX
Int J Clin Pract; 2008 Jun; 62(6):955-60. PubMed ID: 17983435
[TBL] [Abstract][Full Text] [Related]
11. Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi.
Gitura B; Joshi MD; Lule GN; Anzala O
East Afr Med J; 2007 Oct; 84(10):466-72. PubMed ID: 18232267
[TBL] [Abstract][Full Text] [Related]
12. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
Susaengrat W; Mitchai M; Leerattanapetch N
J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
[TBL] [Abstract][Full Text] [Related]
13. Predicting CD4 count using total lymphocyte count: a sustainable tool for clinical decisions during HAART use.
Mwamburi DM; Ghosh M; Fauntleroy J; Gorbach SL; Wanke CA
Am J Trop Med Hyg; 2005 Jul; 73(1):58-62. PubMed ID: 16014833
[TBL] [Abstract][Full Text] [Related]
14. Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients.
van der Ryst E; Kotze M; Joubert G; Steyn M; Pieters H; van der Westhuizen M; van Staden M; Venter C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):238-44. PubMed ID: 9803965
[TBL] [Abstract][Full Text] [Related]
15. Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya.
Githinji N; Maleche-Obimbo E; Nderitu M; Wamalwa DC; Mbori-Ngacha D
BMC Infect Dis; 2011 Sep; 11():259. PubMed ID: 21961890
[TBL] [Abstract][Full Text] [Related]
16. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
Kamya MR; Semitala FC; Quinn TC; Ronald A; Njama-Meya D; Mayanja-Kizza H; Katabira ET; Spacek LA
Afr Health Sci; 2004 Aug; 4(2):94-101. PubMed ID: 15477187
[TBL] [Abstract][Full Text] [Related]
17. Absolute lymphocyte count as a surrogate marker for CD4 counts after six months of HAART initiation in a resource-limited setting in India.
Srirangaraj S; Venkatesha D
Indian J Med Res; 2012 Jun; 135(6):895-900. PubMed ID: 22825609
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings.
Badri M; Wood R
AIDS; 2003 Mar; 17(4):541-5. PubMed ID: 12598774
[TBL] [Abstract][Full Text] [Related]
19. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries.
Kumarasamy N; Mahajan AP; Flanigan TP; Hemalatha R; Mayer KH; Carpenter CC; Thyagarajan SP; Solomon S
J Acquir Immune Defic Syndr; 2002 Dec; 31(4):378-83. PubMed ID: 12447007
[TBL] [Abstract][Full Text] [Related]
20. TOTAL LYMPHOCYTE COUNT AS A SUBSTITUTE TO CD4 COUNT IN MANAGEMENT OF HIV INFECTED INDIVIDUALS IN RESOURCE LIMITED SOCIETY.
Daud MY; Qazi RA; Bashir N
J Ayub Med Coll Abbottabad; 2015; 27(1):29-31. PubMed ID: 26182731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
